Related Experiment Video
Updated: May 14, 2026
07:34
Induction of Acute Ischemic Stroke in Mice Using the Distal Middle Artery Occlusion Technique
Published on: December 15, 2023
Lipoxygenase: an emerging target for stroke therapy.
1Neuroprotection Research Laboratory, Department of Radiology, Massachusetts General Hospital, 149 13th St., R. 2401, Charlestown, MA 02129, USA. klaus_vanleyen@hms.harvard.edu
CNS & Neurological Disorders Drug Targets
|February 12, 2013
Summary
Neuroprotection strategies for stroke therapy are advancing with new drug targets. Inhibiting 12/15-Lipoxygenase (12/15-LOX) may protect against neuronal death and vascular injury in stroke.
Area of Science:
- Neuroscience
- Pharmacology
- Biochemistry
Background:
- Stroke therapy requires improved acute care and novel drug targets.
- 12/15-Lipoxygenase (12/15-LOX) is implicated in neuronal cell death and vascular injury during ischemic events.
- The arachidonic acid cascade involves key enzymes like 12/15-LOX.
Purpose of the Study:
- To review the role of 12/15-Lipoxygenase (12/15-LOX) in stroke.
- To explore the potential of inhibiting 12/15-LOX for neuroprotection and stroke therapy.
- To discuss targeting 12/15-LOX and related eicosanoid pathways.
Main Methods:
- Literature review of studies on 12/15-LOX and stroke.
- Analysis of the arachidonic acid cascade in the context of ischemic injury.
- Examination of potential therapeutic strategies targeting 12/15-LOX.
Main Results:
- 12/15-LOX contributes significantly to neuronal and vascular damage in stroke.
- Inhibition of 12/15-LOX shows potential for multifactorial protection against ischemic injury.
- Eicosanoid pathways related to 12/15-LOX are viable therapeutic targets.
Conclusions:
- Targeting 12/15-LOX offers a promising approach for neuroprotection in stroke.
- Inhibiting 12/15-LOX may mitigate both neuronal cell death and vascular injury.
- Further research into 12/15-LOX inhibitors could lead to improved stroke treatments.
Related Concept Videos
01:15Ischemic Stroke ll: Pathophysiology
An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
01:15Ischemic Stroke l: Introduction
Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
01:29Hemorrhagic Stroke ll: Pathophysiology
A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
01:17Hemorrhagic Stroke l: Introduction
A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:26Transient Ischemic Attack l: Introduction
A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...